Estrogen/progestogen Receptor
The estrogen/progestogen receptors are activated by the hormone estrogen/progesterone and regulate the gene transcription.
Products Related to Estrogen/progestogen Receptor(156)
- GC10180CyclofenilCAS: 2624-43-3Purity: >98%
Non-steroidal selective estrogen receptor modulator (SERM)
- GC10389ERB 041CAS: 524684-52-4Purity: >98.00%
ERB 041 (ERB-041) is a potent and selective estrogen receptor (ER) β agonist with IC50s of 5.4, 3.1 and 3.7 nM for human, rat and mouse ERβ, respectively. ERB 041 displays >200-fold selectivity for ERβ over ERα. ERB 041 is a potent skin cancer chemopreventive agent that acts by dampening the WNT/β-catenin signaling pathway. ERB 041 induces ovarian cancer apoptosis.
- GC11144Chlormadinone acetateCAS: 302-22-7Purity: >98.00%
steroidal progestin with additional antiandrogen and antigonadotropic effects
- GC11425Lasofoxifene (tartrate)CAS: 190791-29-8Purity: >99.50%
third-generation, non-steroidal selective estrogen receptor modulator (SERM)
- GC116064-Methylbenzylidene camphorCAS: 36861-47-9Purity: >99.50%
ultraviolet light blocker used in cosmetics and sunscreen preparations that also has estrogenic activities.
- GC11863PHTPPCAS: 805239-56-9Purity: >98.00%
PHTPP is a selective ERβ full antagonist with 36-fold selectivity for ERβ over ERα. PHTPP can selectively antagonize the ligand binding and transcriptional functions of ERβ, blocking its inhibitory effect on tumor cells, thereby promoting cell proliferation. PHTPP was used to verify ERβ function.
- GC11881MPP dihydrochlorideCAS: 911295-24-4Purity: >98.00%
MPP dihydrochloride is a selective estrogen receptor α (ERα) antagonist.
- GC11996OspemifeneCAS: 128607-22-7Purity: >99.50%
non-hormonal selective estrogen receptor modulator (SERM)
- GC12644QuinestrolCAS: 152-43-2Purity: >98.00%
synthetic estrogen that is effective in hormone replacement therapy
- GC12767ZearalenoneCAS: 17924-92-4Purity: >98.00%
Zearalenone is an estrogenic fusariotoxin that binds to estrogen receptors, including the 17β-estradiol-specific subtype.
- GC139174’-hydroxy TamoxifenCAS: 82413-23-8Purity: ≥98% (may contain up to 10% of the (E) isomer)
metabolite of tamoxifen, an estrogen receptor modulator
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10012 | Chlorotrianisene | 569-57-3 | >99.00% | |
Estrogen agonist | ||||
| GC10180 | Cyclofenil | 2624-43-3 | >98% | |
Non-steroidal selective estrogen receptor modulator (SERM) | ||||
| GC10346 | Y 134 | 849662-80-2 | >98.00% | |
estrogen receptor modulator | ||||
| GC10389 | ERB 041 | 524684-52-4 | >98.00% | |
ERB 041 (ERB-041) is a potent and selective estrogen receptor (ER) β agonist with IC50s of 5.4, 3.1 and 3.7 nM for human, rat and mouse ERβ, respectively. ERB 041 displays >200-fold selectivity for ERβ over ERα. ERB 041 is a potent skin cancer chemopreventive agent that acts by dampening the WNT/β-catenin signaling pathway. ERB 041 induces ovarian cancer apoptosis. | ||||
| GC10558 | GSK 4716 | 101574-65-6 | >98.00% | |
estrogen-related receptors ERRβ and ERRγ agonist | ||||
| GC10663 | Dihydrodaidzein | 17238-05-0 | >98.00% | |
estrogen receptor agonist | ||||
| GC10684 | Zearalanone | 5975-78-0 | >98.00% | |
estrogen receptor agonist | ||||
| GC10852 | Bazedoxifene acetate | 198481-33-3 | >99.50% | |
A selective estrogen receptor modulator | ||||
| GC11144 | Chlormadinone acetate | 302-22-7 | >98.00% | |
steroidal progestin with additional antiandrogen and antigonadotropic effects | ||||
| GC11425 | Lasofoxifene (tartrate) | 190791-29-8 | >99.50% | |
third-generation, non-steroidal selective estrogen receptor modulator (SERM) | ||||
| GC11544 | Toremifene | 89778-26-7 | >98% | |
| GC11606 | 4-Methylbenzylidene camphor | 36861-47-9 | >99.50% | |
ultraviolet light blocker used in cosmetics and sunscreen preparations that also has estrogenic activities. | ||||
| GC11734 | α-Zearalenol | 36455-72-8 | >98.00% | |
estrogen receptor agonist | ||||
| GC11863 | PHTPP | 805239-56-9 | >98.00% | |
PHTPP is a selective ERβ full antagonist with 36-fold selectivity for ERβ over ERα. PHTPP can selectively antagonize the ligand binding and transcriptional functions of ERβ, blocking its inhibitory effect on tumor cells, thereby promoting cell proliferation. PHTPP was used to verify ERβ function. | ||||
| GC11881 | MPP dihydrochloride | 911295-24-4 | >98.00% | |
MPP dihydrochloride is a selective estrogen receptor α (ERα) antagonist. | ||||
| GC11996 | Ospemifene | 128607-22-7 | >99.50% | |
non-hormonal selective estrogen receptor modulator (SERM) | ||||
| GC12140 | Endoxifen | 112093-28-4 | >98% | |
Endoxifen Z-isomer is the most important Tamoxifen metabolite responsible for eliciting the anti-estrogenic effects of this drug in breast cancer cells expressing estrogen receptor-alpha (ERα). | ||||
| GC12644 | Quinestrol | 152-43-2 | >98.00% | |
synthetic estrogen that is effective in hormone replacement therapy | ||||
| GC12766 | G-1 | 881639-98-1 | >99.50% | |
G-1 is a selective and potent agonist of GPR30 with EC50 value about 2 nM. | ||||
| GC12767 | Zearalenone | 17924-92-4 | >98.00% | |
Zearalenone is an estrogenic fusariotoxin that binds to estrogen receptors, including the 17β-estradiol-specific subtype. | ||||
| GC13309 | WAY 200070 | 440122-66-7 | >99.00% | |
ERβ receptor agonist | ||||
| GC13373 | (R)-DPN | 524047-78-7 | >98% | |
estrogen receptor (ER) β agonist | ||||
| GC13917 | 4’-hydroxy Tamoxifen | 82413-23-8 | ≥98% (may contain up to 10% of the (E) isomer) | |
metabolite of tamoxifen, an estrogen receptor modulator | ||||
| GC14131 | FERb 033 | 1111084-78-6 | >98% | |
ERβ receptor agonist | ||||
